Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Steve33on Jun 07, 2021 10:24am
110 Views
Post# 33339653

RE:RE:Market Cap 172 millions only?

RE:RE:Market Cap 172 millions only?
Thanks for being reasonable as a bunch of others are nonsense. Anyways my take is the next news release will reveal their true intentions. It will be some form of guidance. We'll know in our hearts to leave and never return or possibly stay with our fingers on the trigger. Any BS at this point I'm out forever.
<< Previous
Bullboard Posts
Next >>